Retevmo 80 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q0J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,166
Award facts
- Contract value 100% obligated
- $16,165.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,165.92 to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of RETEVMO 80 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, and performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor in the federal medical supply chain and holds substantial contracts with DLA to support military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains to support military healthcare programs worldwide. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen Drug Corp as a key provider within the DLA's strategic pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DR26F9Q0J?
SPE2DR26F9Q0J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F9Q0J worth?
The government has obligated $16,166 on SPE2DR26F9Q0J.
Is contract SPE2DR26F9Q0J an order under another contract?
Yes. SPE2DR26F9Q0J is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9Q0J competed?
The extent of competition for SPE2DR26F9Q0J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award